Trial
NCT00503880
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Nebraska
Collaborators
National Cancer Institute (NCI)
Condition
Myelodysplastic Syndromes
Intervention
filgrastim
Why stopped
Genzyme discontinued Funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-18